日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Pharma association issues report on innovative drugs

By Liu Zhihua | chinadaily.com.cn | Updated: 2021-04-21 17:44
Share
Share - WeChat
The Executive Committee of the Research & Development-based Pharmaceutical Association Committee under the China Association of Enterprises with Foreign Investment held an event on Tuesday to release a report on the innovative pharmaceutical industry and its role in the implementation of the Healthy China 2030 initiative. [Photo provided to chinadaily.com.cn]

A total of 200 innovative drugs have been approved in China over the past five years, among which many have been included in public-funded medical insurance programs, according to a recent report by the Executive Committee of the Research & Development-based Pharmaceutical Association Committee under the China Association of Enterprises with Foreign Investment.

Focusing on the innovative pharmaceutical industry and its role in the implementation of the Healthy China 2030 initiative, the report said about 33 percent of innovative drugs approved in the past five years are tumor treatments, and about 80 percent of the drugs, or 156 titles, are from multinational pharmaceutical companies.

The innovative drugs registered by multinational pharmaceutical companies have also showed more diversity in the past five years, as the share of tumor treatments has dropped to 33 percent from 47 percent in the period from 2010 to 2015, while more drugs for diseases related to the nervous system, digestion and the cardiovascular and respiratory systems have been registered.

Yang Ying, vice-president of Worldwide Business Development Asia at US-based pharmaceutical company Pfizer, said foreign pharmaceutical enterprises see China not only as an important market, but also an important investment destination for both commercialization and research and development.

As Chinese enterprises show increasing innovation capabilities, there are more cooperation opportunities for foreign and domestic enterprises in pharmaceutical industry, she said.

However, high costs and patients' lack of access to innovative drugs still remain a problem for the innovative pharmaceutical industry in China, according to the report.

Innovative drugs only account for about 9 percent of the total pharmaceutical market in China, the world's second-largest pharmaceutical market in the world, while in other G20 member countries the figure is all above 20 percent, and in developed countries such as the United States, Japan and Germany, the figure is more than 50 percent.

Kang Wei, managing director of RDPAC, suggested promoting the development of commercial insurance to increase the accessibility of innovative drugs and thus better meet Chinese patients' clinical demands.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 国产精品久久久爽爽爽麻豆色哟哟 | 久久日本精品一区二区三区 | 操出白浆在线观看 | 午夜午夜精品一区二区三区文 | 超碰伊人网 | 日本一二三区视频 | 精品自拍视频 | 国产欧美日韩亚洲精品区2345 | 无码又黄又爽又舒服的A片 综合久久网 | 欧美成人a∨高清免费观看 毛片特级 | 亚洲成人一区 | 色综合久久手机在线 | 麻豆免费永久网址入口网址 | 午夜视频在线免费播放 | 午夜视频一区二区 | 国产欧美日本亚洲精品五区 | 99久久精品国产免看国产一区 | 四虎影视永久免费观看网址 | 久久综合五月开心婷婷深深爱 | 亚洲草原天堂 | 色欧美片视频在线观看 | 亚洲人人| 亚洲欧美中文日韩在线 | 91制服| 国产99久久亚洲综合精品 | 激情六月综合 | 亚洲第一黄色网址 | 亚洲一区二区久久 | 精品国产91亚洲一区二区三区www | 久草在线免费福利视频 | 亚洲精品美女久久久 | 国产精品欧美日韩 | 青草青草久热精品视频在线网站 | 欧美精品在线一区二区三区 | 欲色av | 久草免费新视频 | 久久精品无码一区二区日韩av | 精品国产一区二区三区久久久 | 天天插天天 | 开心伊人 | 9久9久女女热精品视频免费观看 |